Clinical Trial Update: Human Urine Sample Collection for Alport Nephropathy Biomarker Studies

View source ↗

Summary

A Novartis-sponsored clinical trial studying urine biomarkers for Alport syndrome has terminated, marking the withdrawal of the trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alport Syndrome

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Alport Syndrome | Status: TERMINATED